Tech Company Financing Transactions
Cohera Medical Funding Round
On 10/17/2008, Cohera Medical raised $16.1 million in Series B funding from Kern Whelan Capital and private investors.
Transaction Overview
Company Name
Announced On
10/17/2008
Transaction Type
Venture Equity
Amount
$16,100,000
Round
Series B
Investors
Kern Whelan Capital (Jay Kern)
Proceeds Purpose
For the ongoing development of TissuGlu®, a novel surgical adhesive for application in plastic surgery.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
227 Fayetteville St. 900
Raleigh, NC 27601
USA
Raleigh, NC 27601
USA
Phone
Website
Email Address
Overview
Cohera Medical, Inc. is aimed at fulfilling the market demand for a strong, safe tissue adhesive to improve the wound closure process by positioning tissues for optimal healing while minimizing fluid accumulation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Daly
Chief Scientific Officer
Dottie Clower
Vice President
Mart Pearson
VP - Finance
Justin Alexander
VP - General Counsel
Chad Coberly
VP - Sales
John Wyatt
Browse more venture capital transactions:
Prev: 10/17/2008: V.i. Laboratories venture capital transaction
Next: 10/17/2008: T2 Biosystems venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs